Cutaneous Malignant Melanoma in Western Australia

References

• Heenan P J, Holman C DJ. Survival from invasive cutaneous malignant melanoma in Western Australia and the Oxford Region: a comparative histological study of high and low incidence populations. Pathology 1983; 15: 147–52
   Web of Science ®Google Scholar
• ten Seldam R EJ, Helwig E B, Sobin L H, Torloni H. Histological typing of skin tumours. International Histological Classification of Tumours No. 12. World Health Organization, Geneva 1974
   Google Scholar
• McGovern V J, Caldwell R A, Duncan C A, et al. Moles and malignant melanoma: terminology and classification. Med J Aust 1967; 1: 123–5
   Google Scholar
• Clark W H, Jr. A classification of malignant melanoma in man correlated with histogenesis and biological behaviour. Advances in biology of skin. Vol. VIII, The pigmentary system, W Montagna, F Hu. Pergamon Press, Oxford and New York 1967; 621–47
   Google Scholar
• Clark W H, Jr, Ainsworth A M, Bernardino E A, et al. The developmental biology of primary human malignant melanomas. Semin Oncol 1975; 2: 83–103
   PubMedGoogle Scholar
• Clark W H, Jr, Reimer R R, Greene M H, et al. Origin of familial malignant melanomas from heritable melanocytic lesions, “The B-K mole syndrome”. Arch Dermatol 1978; 114: 732–8
   PubMed Web of Science ®Google Scholar
• McGovern V. J. The classification of melanoma and its relationship with prognosis. Pathology 1970; 2: 85–98
   PubMed Web of Science ®Google Scholar
• McGovern V. J. Malignant melanoma: Clinical and histological diagnosis. Wiley, New York 1976
   Google Scholar
• McGovern V J, Shaw H M, Milton G W, Farago G. A. Prognostic significance of the histological features of malignant melanoma. Histopathology 1979; 3: 385–93
   Google Scholar
• Beardmore G. L. The epidemiology of malignant melanoma in Australia, Melanoma and skin cancer. Proceedings of the International Cancer Conference, Sydney, 1972, W H McCarthy. Government Printer, 39–64
   Google Scholar
• Little J. H. Histology and prognosis of cutaneous melanoma. Progress in clinical cancer, I M Ariel. Grune & Stratton, New York 1975; Vol. VI: 163–76
   Google Scholar
• Smith T. The Queensland melanoma project—an exercise in health education. Br Med J 1979; 1: 253–4
   Google Scholar
• Breslow A. Thickness cross-sectional area and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902–8
   PubMed Web of Science ®Google Scholar
• Breslow A. Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg 1975; 182: 572–5
   PubMed Web of Science ®Google Scholar
• Holman C DJ, Mulroney C D, Armstrong B. K. Epidemiology of pre-invasive and invasive malignant melanoma in Western Australia. Int J Cancer 1980; 25: 317–23
   PubMed Web of Science ®Google Scholar
• Lee J AH. Current evidence about the cause of malignant melanoma. Progress in clinical cancer, I M Ariel. Grune & Stratton, New York 1975; Vol. VI: 151–61
   Google Scholar
• Cutchis P. On the linkage of solar ultraviolet radiation to skin cancer. Institute of Defense Analyses Paper P-1342. US Department of Transportation, Washington, DC 1978; 105–6
   Google Scholar
• Fears T R, Scotto J, Schneiderman M. A. Mathematical models of age and ultra violet effects on the incidence of skin cancer among whites in the United States. Am J Epidemiol 1977; 105: 420–7
   PubMed Web of Science ®Google Scholar
• Heenan P J, Holman C DJ. A histological comparison of cutaneous malignant melanoma between the Oxford Region and Western Australia. Histopathology 1982; 6: 703–16
   Google Scholar
• Eldh J, Boeryd B, Peterson L. D. Prognostic factors in cutaneous malignant melanoma in stage I. Scand J Reconst Surg 1978; 12: 243–55
   PubMed Web of Science ®Google Scholar
• Balch C M, Murad T M, Soong S, et al. A multifactorial analysis of melanoma: 1. Prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg 1978; 188: 732–42
   Google Scholar
• McGovern V J, Mihm M C, Bailey C, et al. The classification of malignant melanoma and its histologic reporting. Cancer 1973; 32: 1446–57
   PubMed Web of Science ®Google Scholar
• Little J. H. Histology and prognosis in cutaneous malignant melanoma. Melanoma and skin cancer. Proceedings of the International Cancer Conference, Sydney, 1972, W H McCarthy. Government Printer, 107–19
   Google Scholar
• Larsen T E, Grude T. H. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. Acta Pathol Microbiol Scand 1978; 86: 437–50
   Google Scholar
• Ironside P, Pitt T TE, Rank B. K. Malignant melanoma: some aspects of pathology and prognosis. Aust NZ J Surg 1977; 47: 70–5
   PubMedGoogle Scholar
• Swerdlow A. J. Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine. Br Med J 1979; 2: 1324–7
   PubMed Web of Science ®Google Scholar
• Little J H, Holt J, Davis N. Changing epidemiology of malignant melanoma in Queensland. Med J Aust 1980; 1: 66–9
   Google Scholar
• Shaw H M, McGovern V J, Milton G W, et al. Histological features of tumours and the female superiority in survival from malignant melanoma. Cancer 1980; 45: 1604–8
   Google Scholar
• Rampen F HJ, Mulder J. H. Malignant melanoma: an androgen-dependent tumour. Lancet 1980; 1: 562–4
   Google Scholar
• Lemish W M, Heenan P J, Holman C DJ, Armstrong B. K. Survival from pre-invasive and invasive malignant melanoma in Western Australia. Cancer 1983; 52: 580–5
   Google Scholar
• Briggs J. C. Frequency of “thin” malignant melanoma. Lancet 1980; 1: 432–3
   Google Scholar
• Heenan P J, Mulroney C, Holman C DJ, Armstrong B. K. Frequency of thin malignant melanoma. Lancet 1980; 2: 530
   Google Scholar
• Heenan P J, Weeramanthri T, Holman C DJ, Armstrong B. K. Surgical treatment and survival from cutaneous malignant melanoma. Aust NZ J Surg
   Google Scholar
• Elder D E, Guerry D I V, Heiberger R M, et al. Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg 1983; 71: 66–72
   PubMed Web of Science ®Google Scholar
• Cascinelli N, van der Esch E P, Breslow A, et al. Stage I melanoma of the skin: the problem of resection margins. Eur J Cancer 1980; 16: 1079–85
   PubMedGoogle Scholar
• Bagley F H, Cady B, Lee A, Legg M. A. Changes in clinical presentation and management of malignant melanoma. Cancer 1981; 47: 2126–34
   PubMed Web of Science ®Google Scholar
• McCarthy W H, Dobson A J, Martyn A L, Roberts G. Melanoma in New South Wales 1970–76: surgical therapy and survival. Aust NZ J Surg 1982; 52: 424–30
   PubMedGoogle Scholar
• Day C L, Jr, Mihm M C, Jr, Sober A, et al. Narrower margins for clinical stage I malignant melanoma. N Engl J Med 1982; 306: 479–82
   PubMed Web of Science ®Google Scholar
• Handley W. S. The pathology of melanotic growths in relation to their operative treatment. Lancet 1907; 1: 927–33; 996–1003
   Google Scholar
• Byrne M J, Van Hazel G, Reynolds P M, et al. Adjuvant immunotherapy with BCG in stage II malignant melanoma. J Surg Oncol 1983; 23: 114–6
   Google Scholar
• Morton D L, Holmes E C, Eilber F R, Ramming K. P. Adjuvant immunotherapy of malignant melanoma: Results of a randomised trial in patients with lymph node metastases. Presented at the Second Intermedical Conference on Immunotherapy of Cancer, Bethesda, Maryland, April, 28–301980
   Google Scholar
• Hawkins B R, Dawkins R L, Hockey A, et al. Evidence for linkage between HLA and malignant melanoma. Tissue Antigens 1981; 17: 540–1
   Google Scholar
• Fleiss J. L. Measuring nominal scale agreement among many raters. Psychol Bull 1971; 76: 378–82
   Web of Science ®Google Scholar
• Holman C DJ, James R, Heenan P J, et al. An improved method of analysis of observer variation between pathologists. Histopathology 1982; 6: 581–9
   PubMed Web of Science ®Google Scholar
• Prade M, Sancho-Garnier H, Cesarini J P, Cochran A. Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma. Int J Cancer 1980; 26: 159–63
   PubMedGoogle Scholar
• Suffin S C, Waisman J, Clark W H, Jr, Morton D. L. Comparison of the classification of microscopic level (stage) of malignant melanoma by three independent groups of pathologists. Cancer 1977; 40: 3112–4
   PubMedGoogle Scholar
• Larsen T E, Little J H, Orell S R, Prade M. International pathologists congruence survey on quantitation of malignant melanoma. Pathology 1980; 12: 245–53
   PubMed Web of Science ®Google Scholar
• Heenan P J, Matz L R, Blackwell J B, et al. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in Western Australia. Histopathology 1984; 8: 717–29
   PubMedGoogle Scholar
• Elder D E, Goldman L I, Goldman S C, et al. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer 1980; 46: 1787–94
   PubMed Web of Science ®Google Scholar
• Holman C DJ, Armstrong B K, Heenan P. J. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst 1983; 71: 651–6
   PubMedGoogle Scholar
• Houghton A N, Viola M. V. Solar radiation and malignant melanoma of the skin. J Am Acad Dermatol 1981; 5: 477–83
   PubMed Web of Science ®Google Scholar
• Epstein J H, Epstein W L, Nakai T. Production of melanoma from DMBA-induced “blue nevi” in hairless mice with ultraviolet light. J Natl Cancer Inst 1967; 38: 19–30
   PubMed Web of Science ®Google Scholar
• Magnus K. Habits of sun exposure and risk of malignant melanoma: An analysis of incidence rates in Norway 1955–1977 by cohort, sex, age and primary tumor site. Cancer 1981; 48: 2329–35
   PubMed Web of Science ®Google Scholar
• Mishima Y. Melanocytic and nevocytic malignant melanoma. Cellular and subcellular differentiation. Cancer 1967; 20: 632–49
   Google Scholar
• Holman C D, Heenan P J, Caruso V, et al. Seasonal variation in the junctional component of pigmented naevi. Int J Cancer 1983; 31: 213–5
   Google Scholar
• Heenan P J, Holman C. D. Nodular malignant melanoma—a distinct entity or a common end stage. Am J Dermatopathol 1982; 4: 477–8
   Google Scholar
• Ackerman A. B. Malignant melanoma. A unifying concept. Hum Pathol 1980; 11: 591–5
   PubMed Web of Science ®Google Scholar
• Holman C DJ, Armstrong B. K. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984; 72: 257–65
   PubMed Web of Science ®Google Scholar
• Cancer incidence in five continents. IARC Sci Publ 1976; 15: 124–31; 164–7; 364–7, Waterhouse J, Muir C, Correa P, Powell J, eds.
   Google Scholar
• Lane Brown M M, Sharpe C A, MacMillen D S, McGovern V. J. Genetic predisposition to melanoma and the other skin cancers in Australians. Med J Aust 1971; 1: 852–3
   Google Scholar
• Lane Brown M M, Melia D F. “Celticity” and cutaneous malignant melanoma in Massachusetts. Pigment cell. Vol. I. Mechanisms in pigmentation, V McGovern, P Russell. Karger, Basel 1973; 229–35
   Google Scholar
• Adam S A, Sheaves J K, Wright N H, et al. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer 1981; 44: 45–50
   PubMed Web of Science ®Google Scholar
• Holman C DJ, Armstrong B. K. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984; 73: 75–82
   PubMed Web of Science ®Google Scholar
• Holman C DJ, Armstrong B K, Heenan P. J. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 1984; 50: 673–80
   PubMed Web of Science ®Google Scholar
• Beral V, Ramcharan S, Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 1977; 36: 804–9
   PubMed Web of Science ®Google Scholar
• Holly E A, Weiss N S, Liff J. M. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst 1983; 70: 827–31
   PubMedGoogle Scholar
• Beral V, Evans S, Shaw H, Milton G. Malignant melanoma and exposure to fluorescent lighting at work. Lancet 1982; 2: 290–3
   PubMed Web of Science ®Google Scholar
• Pasternack B S, Dubin N, Moseson M. Malignant melanoma and exposure to fluorescent lighting at work. Lancet 1983; 1: 704
   Google Scholar
• English D R, Rouse I L, Zhong X, et al. Cutaneous malignant melanoma and fluorescent lighting, unpublished data
   Google Scholar
• Elder D E, Greene M H, Bondi E E, Clark W H, Jr. Acquired melanocytic nevi and melanoma: the dysplascic nevus syndrome. Pathology of malignant melanoma, A B Ackerman. Masson, New York 1981; 185–215
   Google Scholar